• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在急诊科中,比较使用凝血酶原复合物浓缩物和血浆进行药物管理的物流。

Comparison of drug administration logistics between prothrombin complex concentrates and plasma in the emergency department.

机构信息

Department of Pharmaceutical Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O Box 84428, Riyadh, Saudi Arabia; Department of Pharmacy Practice and Science, College of Pharmacy, The University of Arizona, 1295 N Martin Ave, PO Box 210202, Tucson, AZ 85721, USA.

Department of Pharmacy Practice and Science, College of Pharmacy, The University of Arizona, 1295 N Martin Ave, PO Box 210202, Tucson, AZ 85721, USA.

出版信息

Am J Emerg Med. 2018 Dec;36(12):2182-2186. doi: 10.1016/j.ajem.2018.03.064. Epub 2018 Mar 24.

DOI:10.1016/j.ajem.2018.03.064
PMID:29622392
Abstract

BACKGROUND

Prothrombin complex concentrate (PCC) is used as an alternative to fresh frozen plasma (FFP) for emergency bleeding. The primary objective of this study was to compare the time from order to start of administration between 3-factor PCC (PCC3), 4-factor (PCC4), and FFP in the emergency department (ED). The secondary objective was to evaluate the effect of an ED pharmacist on time to administration of PCCs.

METHODS

This was a single center three-arm retrospective cohort study. Adult patients in the ED with bleeding were included. The primary outcome measure was the time from order to administration, which was compared between PCC3, PCC4, and FFP. The time from order to administration was also compared when the ED pharmacist was involved versus not involved in the care of patients receiving PCC.

RESULTS

There were 90 patients included in the study cohort (30 in each group). The median age was 69years (IQR 57-82years), and 57% (n=52) were male. The median time from order to administration was 36min (IQR 20-58min) for PCC3, 34min (IQR 18-48min) for PCC4, and 92min (IQR 63-133) for FFP (PCC3 versus PCC4, p=0.429; PCC3 versus FFP, p<0.001; PCC4 versus FFP, p<0.001). The median time from order to administration was significantly decreased when the ED pharmacist was involved (24min [IQR 15-35min] versus 42min [IQR 32-59min], p<0.001).

CONCLUSIONS

Time from order to administration is faster with PCC than FFP. ED pharmacist involvement decreases the time from order to administration of PCC.

摘要

背景

凝血酶原复合物浓缩物(PCC)可替代新鲜冷冻血浆(FFP)用于紧急出血。本研究的主要目的是比较 3 因子 PCC(PCC3)、4 因子(PCC4)和 FFP 在急诊科(ED)开始给药的时间。次要目的是评估 ED 药师对 PCC 给药时间的影响。

方法

这是一项单中心三臂回顾性队列研究。ED 中有出血的成年患者被纳入研究。主要观察指标是从医嘱到给药的时间,比较 PCC3、PCC4 和 FFP 之间的差异。当 ED 药师参与或不参与接受 PCC 治疗的患者的护理时,从医嘱到给药的时间也进行了比较。

结果

研究队列共纳入 90 例患者(每组 30 例)。中位年龄为 69 岁(IQR 57-82 岁),57%(n=52)为男性。从医嘱到给药的中位时间为 PCC3 组 36 分钟(IQR 20-58 分钟),PCC4 组 34 分钟(IQR 18-48 分钟),FFP 组 92 分钟(IQR 63-133 分钟)(PCC3 与 PCC4 相比,p=0.429;PCC3 与 FFP 相比,p<0.001;PCC4 与 FFP 相比,p<0.001)。当 ED 药师参与时,从医嘱到给药的中位时间显著缩短(24 分钟[IQR 15-35 分钟]与 42 分钟[IQR 32-59 分钟]相比,p<0.001)。

结论

与 FFP 相比,PCC 从医嘱到给药的时间更快。ED 药师的参与缩短了 PCC 的给药时间。

相似文献

1
Comparison of drug administration logistics between prothrombin complex concentrates and plasma in the emergency department.在急诊科中,比较使用凝血酶原复合物浓缩物和血浆进行药物管理的物流。
Am J Emerg Med. 2018 Dec;36(12):2182-2186. doi: 10.1016/j.ajem.2018.03.064. Epub 2018 Mar 24.
2
Propensity score adjusted comparison of three-factor versus four-factor prothrombin complex concentrate for emergent warfarin reversal: a retrospective cohort study.三因子与四因子凝血酶原复合物浓缩物用于紧急华法林逆转的倾向评分调整比较:一项回顾性队列研究。
BMC Emerg Med. 2020 Nov 26;20(1):93. doi: 10.1186/s12873-020-00386-z.
3
Comparison of blood product use and costs with use of 3-factor versus 4-factor prothrombin complex concentrate for off-label indications.非标签适应症使用三因子与四因子凝血酶原复合物浓缩物时血液制品使用情况及成本的比较。
Am J Health Syst Pharm. 2018 Aug 1;75(15):1103-1109. doi: 10.2146/ajhp180076. Epub 2018 Jun 25.
4
Feasibility of a Collaborative, Prospective Interdisciplinary Review and Pharmacy-Based Dispensing Process for Prothrombin Complex Concentrate.前瞻性协作式多学科审查及基于药学的凝血酶原复合物浓缩物配药流程的可行性。
Ann Pharmacother. 2018 May;52(5):454-461. doi: 10.1177/1060028017750397. Epub 2018 Jan 9.
5
Use and effectiveness of prothrombin complex concentrates vs fresh frozen plasma in gastrointestinal hemorrhage due to warfarin usage in the ED.在急诊科华法林所致胃肠道出血中凝血酶原复合物浓缩剂与新鲜冰冻血浆的应用及疗效比较
Am J Emerg Med. 2014 Jun;32(6):660-4. doi: 10.1016/j.ajem.2014.02.016. Epub 2014 Feb 24.
6
Thromboembolic Risk of 4-Factor Prothrombin Complex Concentrate versus Fresh Frozen Plasma for Urgent Warfarin Reversal in the Emergency Department.急诊紧急华法林逆转中 4 因子凝血酶原复合物浓缩物与新鲜冷冻血浆的血栓栓塞风险比较。
West J Emerg Med. 2019 Jul;20(4):619-625. doi: 10.5811/westjem.2019.4.41649. Epub 2019 Jun 11.
7
Comparison of Fresh-Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study.新鲜冰冻血浆、四因子凝血酶原复合物浓缩剂和重组凝血因子VIIa用于促进肝病凝血功能障碍重症患者手术操作的比较:一项回顾性队列研究
Pharmacotherapy. 2016 Oct;36(10):1047-1054. doi: 10.1002/phar.1827. Epub 2016 Sep 22.
8
Safety and Effectiveness of Factor VIII Inhibitor Bypassing Activity (FEIBA) and Fresh Frozen Plasma in Oral Anticoagulant-Associated Intracranial Hemorrhage: A Retrospective Analysis.凝血因子 VIII 抑制物旁路活性制剂(FEIBA)和新鲜冰冻血浆用于口服抗凝剂相关颅内出血的安全性和有效性:一项回顾性分析
Neurocrit Care. 2017 Aug;27(1):51-59. doi: 10.1007/s12028-017-0383-x.
9
Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial.新鲜冷冻血浆与凝血酶原复合物浓缩物治疗维生素 K 拮抗剂相关颅内出血患者(INCH):一项随机试验。
Lancet Neurol. 2016 May;15(6):566-73. doi: 10.1016/S1474-4422(16)00110-1. Epub 2016 Apr 11.
10
The role of four-factor prothrombin complex concentrate in coagulopathy of trauma: A propensity matched analysis.四因子凝血酶原复合物浓缩物在创伤性凝血病中的作用:倾向评分匹配分析。
J Trauma Acute Care Surg. 2018 Jul;85(1):18-24. doi: 10.1097/TA.0000000000001938.

引用本文的文献

1
Impact of Pharmacist Preparation of Four-Factor Prothrombin Complex Concentrate at the Bedside in Patients with Life-Threatening Hemorrhage in the Emergency Department.急诊科药师床边配制四因子凝血酶原复合物浓缩剂对危及生命出血患者的影响。
Hosp Pharm. 2025 Feb 21:00185787251321073. doi: 10.1177/00185787251321073.
2
Emergency intensive care unit pharmacist's intervention may reduce time to four-factor prothrombin complex concentrate administration: a retrospective study.急诊重症监护病房药师的干预可能会缩短给予四因子凝血酶原复合物浓缩剂的时间:一项回顾性研究。
J Pharm Health Care Sci. 2020 Apr 3;6:7. doi: 10.1186/s40780-020-00161-z. eCollection 2020.